Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Increasing Dialysate Calcium on Serum Calcification Propensity in Subjects With Secondary Hyperparathyroidism and End-Stage Kidney Disease

NCT06398002 is registered in ClinicalTrials.gov with Iain Bressendorff as lead sponsor.

NCT NCT06398002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06398002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Increasing Dialysate Calcium on Serum Calcification Propensity in Subjects With Secondary Hyperparathyroidism and End-Stage Kidney Disease
Lead sponsor
Iain Bressendorff
Phase
Phase 2
Overall status
Unknown status
Start date
August 1, 2024
Completion date
August 1, 2025
Enrollment
48 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage kidney disease, secondary hyperparathyroidism